Literature DB >> 21903986

Interaction of time-varying albumin and phosphorus on mortality in incident dialysis patients.

Emanuel Zitt1, Claudia Lamina, Gisela Sturm, Florian Knoll, Friederike Lins, Otto Freistätter, Florian Kronenberg, Karl Lhotta, Ulrich Neyer.   

Abstract

BACKGROUND AND OBJECTIVES: Hypoalbuminemia and hyperphosphatemia have been shown to be strong predictors of mortality in dialysis patients that might not be independent from each other. We prospectively investigated the relationship and interaction between serum albumin and phosphorus with all-cause mortality in an inception cohort of incident dialysis patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We followed 235 incident dialysis patients in a prospective single-center cohort study (INVOR study) applying a time-dependent Cox proportional hazards model using all measured laboratory values (2887 albumin and 10306 phosphorus values).
RESULTS: Eighty-two patients (35%) died during a median follow-up of 35.1 months. Albumin was inversely associated with mortality (hazard ratio [95% confidence interval]: 0.23 [0.14 to 0.36]; P < 0.001), whereas higher phosphorus concentrations showed a trend to an increasing risk for mortality (hazard ratio 1.57 [95% confidence interval 0.97 to 2.54]; P = 0.07). Importantly, we observed a significant interaction between albumin and phosphorus (P = 0.01). The lowest risk was found with concurrent low phosphorus and high albumin values, whereas risk was increased with either concurrent low phosphorus and low albumin values or high phosphorus and high albumin values.
CONCLUSIONS: In incident dialysis patients the associations of serum phosphorus and albumin concentrations with mortality are modified by each other over time. Phosphorus-lowering interventions that concomitantly can cause a fall in serum albumin level may be harmful and warrant additional studies. If confirmed, epidemiologic studies and therapeutic guidelines aiming for target values should consider this interplay.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21903986      PMCID: PMC3359564          DOI: 10.2215/CJN.03780411

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  43 in total

Review 1.  Cardiovascular risk in uraemic patients-is it fully explained by classical risk factors?

Authors:  C Zoccali
Journal:  Nephrol Dial Transplant       Date:  2000-04       Impact factor: 5.992

Review 2.  How should hyperphosphatemia be managed in dialysis patients?

Authors:  Geoffrey Block; Jaime Uribarri; Joseph A Coladonato; Stanley L S Fan; John Cunningham; Charles R Nolan; Wajeh Y Qunibi; Jill S Lindberg
Journal:  Semin Dial       Date:  2002 Sep-Oct       Impact factor: 3.455

Review 3.  Vascular calcification and inorganic phosphate.

Authors:  C M Giachelli; S Jono; A Shioi; Y Nishizawa; K Mori; H Morii
Journal:  Am J Kidney Dis       Date:  2001-10       Impact factor: 8.860

4.  Association of serum albumin and atherosclerosis in chronic hemodialysis patients.

Authors:  Srinivasan Beddhu; George A Kaysen; Guofen Yan; Mark Sarnak; Lawrence Agodoa; Daniel Ornt; Alfred K Cheung
Journal:  Am J Kidney Dis       Date:  2002-10       Impact factor: 8.860

5.  Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

Authors:  Geoffrey A Block; Preston S Klassen; J Michael Lazarus; Norma Ofsthun; Edmund G Lowrie; Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2004-08       Impact factor: 10.121

6.  Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study.

Authors:  J Craig Longenecker; Josef Coresh; Neil R Powe; Andrew S Levey; Nancy E Fink; Alice Martin; Michael J Klag
Journal:  J Am Soc Nephrol       Date:  2002-07       Impact factor: 10.121

Review 7.  Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients.

Authors:  Kamyar Kalantar-Zadeh; Gladys Block; Michael H Humphreys; Joel D Kopple
Journal:  Kidney Int       Date:  2003-03       Impact factor: 10.612

8.  Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia.

Authors:  Kerstin Amann; Johannes Törnig; Birgit Kugel; Marie-Luise Gross; Karin Tyralla; Abdussalam El-Shakmak; András Szabo; Eberhard Ritz
Journal:  Kidney Int       Date:  2003-04       Impact factor: 10.612

Review 9.  Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences.

Authors:  Kamyar Kalantar-Zadeh; T Alp Ikizler; Gladys Block; Morrel M Avram; Joel D Kopple
Journal:  Am J Kidney Dis       Date:  2003-11       Impact factor: 8.860

10.  Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population.

Authors:  Jürgen Floege; Joseph Kim; Elizabeth Ireland; Charles Chazot; Tilman Drueke; Angel de Francisco; Florian Kronenberg; Daniele Marcelli; Jutta Passlick-Deetjen; Guntram Schernthaner; Bruno Fouqueray; David C Wheeler
Journal:  Nephrol Dial Transplant       Date:  2010-04-25       Impact factor: 5.992

View more
  15 in total

1.  Predictors of mortality among hemodialysis patients in Hamadan province using random survival forests.

Authors:  Leili Tapak; Vida Sheikh; Ensiyeh Jenabi; Salman Khazaei
Journal:  J Prev Med Hyg       Date:  2020-10-06

2.  High peritoneal transport status was not associated with mortality in peritoneal dialysis patients with diabetes.

Authors:  Naya Huang; Jiehui Chen; Li Fan; Qian Zhou; Qingdong Xu; Ricong Xu; Liping Xiong; Xueqing Yu; Haiping Mao
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

3.  Iron supplementation and mortality in incident dialysis patients: an observational study.

Authors:  Emanuel Zitt; Gisela Sturm; Florian Kronenberg; Ulrich Neyer; Florian Knoll; Karl Lhotta; Günter Weiss
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

Review 4.  The Diet and Haemodialysis Dyad: Three Eras, Four Open Questions and Four Paradoxes. A Narrative Review, Towards a Personalized, Patient-Centered Approach.

Authors:  Giorgina Barbara Piccoli; Maria Rita Moio; Antioco Fois; Andreea Sofronie; Lurlinys Gendrot; Gianfranca Cabiddu; Claudia D'Alessandro; Adamasco Cupisti
Journal:  Nutrients       Date:  2017-04-10       Impact factor: 5.717

5.  Impact of nutritional index on the association between phosphorus concentrations and mortality in haemodialysis patients: a cohort study from dialysis outcomes and practice pattern study in Japan.

Authors:  Shingo Fukuma; Tatsuyoshi Ikenoue; Tadao Akizawa; Shunichi Fukuhara
Journal:  BMJ Open       Date:  2017-08-07       Impact factor: 2.692

6.  Hypoalbuminemia in hemodialyzed end stage renal disease patients: risk factors and relationships--a 2 year single center study.

Authors:  Nagaraja Rao Sridhar; Sowmya Josyula
Journal:  BMC Nephrol       Date:  2013-11-01       Impact factor: 2.388

7.  The Survival of Roma Minority Patients on Chronic Hemodialysis Therapy - A Romanian Multicenter Survey.

Authors:  Florica Gadalean; Daniel Lighezan; Dana Stoian; Oana Schiller; Romulus Timar; Bogdan Timar; Flaviu Bob; Mihaela Dora Donciu; Mircea Munteanu; Adelina Mihaescu; Adrian Covic; Adalbert Schiller
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

8.  Impact of Malnutrition, Inflammation, and Atherosclerosis on the Outcome in Hemodialysis Patients.

Authors:  B B Kirushnan; B Subba Rao; R Annigeri; S Balasubramanian; R Seshadri; K C Prakash; V Vivek
Journal:  Indian J Nephrol       Date:  2017 Jul-Aug

9.  Hidden Hypocalcemia as a Risk Factor for Cardiovascular Events and All-Cause Mortality among Patients Undergoing Incident Hemodialysis.

Authors:  Satoshi Yamaguchi; Takayuki Hamano; Yohei Doi; Tatsufumi Oka; Sachio Kajimoto; Keiichi Kubota; Seiichi Yasuda; Karin Shimada; Ayumi Matsumoto; Nobuhiro Hashimoto; Yusuke Sakaguchi; Isao Matsui; Yoshitaka Isaka
Journal:  Sci Rep       Date:  2020-03-10       Impact factor: 4.379

10.  Changes in serum albumin and other nutritional markers when using sucroferric oxyhydroxide as phosphate binder among hemodialysis patients: a historical cohort study.

Authors:  Kamyar Kalantar-Zadeh; Linda H Ficociello; Vidhya Parameswaran; Nicolaos V Athienites; Claudy Mullon; Robert J Kossmann; Daniel W Coyne
Journal:  BMC Nephrol       Date:  2019-10-29       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.